As Huge Bills Loom, Immunotherapy Pioneer Dendreon Enters Bankruptcy...
11/10/14
![]()
As Huge Bills Loom, Immunotherapy Pioneer Dendreon Enters Bankruptcy
Xconomy
After 22 years, one groundbreaking cancer treatment, and even more ups and downs than the volatile biotech industry would consider normal, Seattle-based Dendreon (NASDAQ: DNDN) has filed for bankruptcy. The company and its prostate-cancer ...
Dendreon's Tale of Woes And Missteps Ends in BankruptcyValueWalk
Dendreon Reaches Agreements on Terms of Financial RestructuringFort Mills Times
[more]
Xconomy
After 22 years, one groundbreaking cancer treatment, and even more ups and downs than the volatile biotech industry would consider normal, Seattle-based Dendreon (NASDAQ: DNDN) has filed for bankruptcy. The company and its prostate-cancer ...
Dendreon's Tale of Woes And Missteps Ends in BankruptcyValueWalk
Dendreon Reaches Agreements on Terms of Financial RestructuringFort Mills Times